Data alert

Managing CV Risk in Diabetes: Setting More Aggressive Goals to Meet a Growing Crisis

The evolving diabetes epidemic is raising concern over the adverse long-term effect on cardiovascular (CV) disease. In just 6 years, from 1997 to 2003, the incidence of self-reported diabetes in the United States increased by 41%. If left unchecked, the escalation in diabetes threatens to counteract the dramatic reductions that have been achieved in CV disease morbidity and mortality over the past 50 years.

Data_Alert.pdf (1.5MB)Data_Alert.pdf (1.5MB)

Growing impact of diabetes on acute MI hospitalizations, 1988 vs 2002

Download VBWG06-DataAlert-TNT.ppt (12 slides - 0.8MB)

Growing impact of diabetes on acute MI hospitalizations, 1988 vs 2002 IVUS shows greater atherosclerotic disease burden in diabetes ADA: Physical activity recommendations in type 2 diabetes and IGT INVEST: Significant predictors of diabetes INVEST: Follow up systolic BP associated with new diabetes Prevention of CV events with lipid lowering by diabetes status: Meta-analysis HPS: Statin beneficial irrespective of baseline lipid level and diabetes status CARDS: Statin reduces primary outcome TNT diabetic analysis: Treatment effects on LDL-C TNT diabetic analysis: First major CV event TNT: MetS increases CV risk regardless of diabetes status AHA/ACC 2006 Secondary prevention guidelines: Risk factor modification in diabetes

References are listed at the end of the Data Alert.


Related at vwbg.org

PROactive: The first prospective clinical outcomes trial of PPAR g agonists

Compared with the general population, persons with diabetes have a twofold greater absolute risk of cardiovascular (CV) disease.

HOPE-TOO: Extended use of ACEI reduces CV risk and new diabetes, independent of baseline risk

Results from large clinical trials provide evidence that angiotensin-converting enzyme inhibitors (ACEIs) are effective in the treatment of cardiovascular (CV) disease.

Role of lipid lowering for prevention of cardiovascular events in type 2 diabetes

Cardiovascular (CV) disease is the primary complication and cause of death in people with type 2 diabetes mellitus, 1 accounting for nearly two thirds of deaths.
More related